Posts

Automation and orchestration of zero trust architecture...

To date, most network security architectures have used perimeter-based defense t...

Discovery brings all-solid-state sodium batteries close...

The pursuit of greener energy also requires efficient rechargeable batteries to ...

Breakthrough promises secure quantum computing at home

The full power of next-generation quantum computing could soon be harnessed by m...

What Is The Endocannabinoid System?

Whether or not you enjoy the benefits of the cannabis plant, your body still pro...

3 Ways CBD Supports Joint Health

CBD, or cannabidiol, is a non-psychoactive compound found in the cannabis plant....

Sensorion raises $16m for gene therapies to treat deafness

Sensorion expects results from a Phase I/II trial of its lead candidate SENS-501...

AdAlta and SYNthesis to form AdCella for advanced cance...

AdAlta has signed an MOU with SYNthesis to explore the creation of a jointly own...

Medicxi and Starpharma to develop dendrimer-based cance...

Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics...

BMS and 2seventy bio’s Abecma gains approval for multip...

Bristol Myers Squibb (BMS) and 2seventy bio’s Abecma have received FDA approval ...

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for s...

The US FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for adults with...

Navigating post-approval research and reimbursement for...

In the second part of this series, F. Randy Vogenberg talks about how planning e...

J&J and Legend’s Carvykti scores early line approval fo...

J&J and Legend’s CAR-T cell therapy has been approved as a second-line therapy f...

Pharmaceutical solid dose (commercial dose) manufacturi...

View the leading pharmaceutical solid dose manufacturing companies in contract m...

FDA accepts Shorla’s oral liquid leukaemia drug NDA

The FDA has approved the NDA for SH-201, an oral liquid drug that slows or stops...

Pluri launches manufacturing division as cell therapy p...

In an interview with Pharmaceutical Technology, Pluri’s CEO discussed its recent...

Dr. Himabindu Vidula is new chair of ACC Board of Gover...

Effective today, Himabindu Vidula, MD, MS, FACC, will serve as chair of the Amer...